Massimo Massi‐Benedetti

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

Diabetes Management, Cardiovascular Disease, Health Policy +10

Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes

Roman Hovorka, Valentina Canonico, Ludovic J. Chassin et al. · Physiological Measurement · 2004 · 1.2K citations

The Effect of Pioglitazone on Recurrent Myocardial Infarction in 2,445 Patients With Type 2 Diabetes and Previous Myocardial Infarction

Erland Erdmann, John Dormandy, B Charbonnel et al. · Journal of the American College of Cardiology · 2007 · 376 citations

Diabetes Management, Cardiovascular Disease, Diabetes +9

Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease

Erland Erdmann, B Charbonnel, Robert A. Wilcox et al. · Diabetes Care · 2007 · 280 citations · Full text

The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive)

B Charbonnel, John Dormandy, Erland Erdmann et al. · Diabetes Care · 2004 · 231 citations